In this episode from the MedTech Unplugged Series, David West, co-founder and CEO of Proscia, joins theCUBE’s Dave Vellante to explore how AI and digital pathology are transforming medical diagnostics. West shares the origin story behind Proscia and its flagship platform, Concentriq, a cloud-native SaaS solution designed to shift pathology from microscope-based workflows to image and data-driven diagnostics. The conversation highlights how Proscia is helping pathologists and life sciences organizations handle massive diagnostic image datasets, some exceeding 100GB in size. West discusses the efficiency gains from using AI and agentic systems to streamline lab operations, reduce reporting burden and accelerate access to advanced therapies. With over $130M in funding and growing adoption across pharma and clinical labs, Proscia is well-positioned at the convergence of AI, precision medicine and value-based care. Additional topics include navigating regulatory hurdles with the FDA and IVDR, Proscia’s dual pricing strategies across diagnostics and life sciences, and how large language models and multimodal AI are enabling new possibilities for patient stratification and workflow automation. West also offers his perspective on the future of AI in healthcare, including the growing role of agents, quality automation and the potential for diagnostics to evolve into a truly data-first discipline.